Table 3 Comparative analysis of frequency of medical insurance claims for purchasing rare disease medications among different patient types at different designated types
Group | Designated type | Frequency of medical insurance claims (%) | P | ||
|---|---|---|---|---|---|
Secondary hospital | Tertiary hospital | Community pharmacy | |||
Total frequency of medical insurance claims | 3(0.1%) | 343(12.0%) | 2505(87.9%) | 2851(100.0%) | |
Medical treatment category | P < 0.001 | ||||
Outpatient | 1(0.0%) | 1(0.0%) | 15(0.5%) | 17(0.6%) | |
Outpatient for major diseases and outpatient for chronic diseases | 0(0.0%) | 11(0.4%) | 1(0.0%) | 12(0.4%) | |
Outpatient special drugs | 0(0.0%) | 190(6.7%) | 2489(87.3%) | 2679(94.0%) | |
Inpatient | 2(0.1%) | 141(4.9%) | 0(0.0%) | 143(5.0%) | |
Health Insurance Schemes | P < 0.001 | ||||
URRBMI | 2(0.1%) | 73(2.6%) | 449(15.8%) | 524(18.4%) | |
UEBMI | 1(0.0%) | 270(9.5%) | 2056(72.1%) | 2327(81.6%) | |
Claims year | P < 0.001 | ||||
2018 | 0(0.0%) | 9(0.3%) | 10(0.4%) | 19 (0.7%) | |
2019 | 0(0.0%) | 80(2.8%) | 105(3.7%) | 185(6.5%) | |
2020 | 0(0.0%) | 137(4.8%) | 631(22.1%) | 768(26.9%) | |
2021 | 3(0.1%) | 117(4.1%) | 1759(61.7%) | 1879(65.9%) | |
Dosage form | P < 0.001 | ||||
Oral agents | 0(0.0%) | 4(0.2%) | 1588(55.6%) | 1592(55.8%) | |
Injection agents | 3(0.1%) | 339(11.9%) | 917(32.2%) | 1259(44.2%) | |